Exploring The Neuropathophysiology Of Autism Spectrum Disorders
Funder
National Health and Medical Research Council
Funding Amount
$417,939.00
Summary
There are currently no validated biomedical techniques for diagnosing or treating autism spectrum disorders (ASD). This project will use cutting-edge neuroscience techniques to better understand the neurobiology of ASD and how neurobiological impairments relate to specific symptoms. These results will promote a better understanding of the brain basis of ASD, and may provide realistic targets for the development of new biomedical methods for diagnosis and treatment.
Prof Fitzgerald a psychiatrist investigating the use of a range of non-drug biological treatments for patients with severe and treatment resistant mood (and related) disorders.
Accelerated Repetitive Transcranial Magnetic Stimulation In The Treatment Of Depression
Funder
National Health and Medical Research Council
Funding Amount
$488,098.00
Summary
rTMS is a new treatment for depression progressively being utilized in clinical practice. However, response to rTMS treatment is usually slow with treatment courses taking over 4-6 weeks. In the current study we will evaluate the efficacy of an accelerated from of rTMS administration: a course of intensive treatment being applied over a 3 day period.
A Double-blind Sham Controlled Trial Of RTMS In Treatment Resistant Major Depression
Funder
National Health and Medical Research Council
Funding Amount
$371,491.00
Summary
Treatment Resistant Depression is clearly a major health issue - depression is common, results in marked morbidity and mortality and a large percentage of patients do not respond to, or cannot tolerate standard treatment. The development of new treatments for this condition is undoubtedly required. International efforts are underway to try and establish the efficacy of high frequency left Transcranial Magnetic Stimulation (HFL-TMS) to the point where the technique may be approved by regulatory a ....Treatment Resistant Depression is clearly a major health issue - depression is common, results in marked morbidity and mortality and a large percentage of patients do not respond to, or cannot tolerate standard treatment. The development of new treatments for this condition is undoubtedly required. International efforts are underway to try and establish the efficacy of high frequency left Transcranial Magnetic Stimulation (HFL-TMS) to the point where the technique may be approved by regulatory authorities and clinically introduced. However, clearly the response rate to HFL-TMS is suboptimal for its widespread use. The overall goal of this research program is to develop repetitive TMS (rTMS) methods to the point at which they are highly relevant and applicable to clinical practice. None of the substantial international studies is focusing on novel applications such as sequential bilateral rTMS (SBrTMS). The planned outcome of this study is that it may change the focus of rTMS application and practice nationally and internationally. If we can follow our well received initial study of this technique with a substantial comparative trial as planned here, it will provide enough evidence for the more widespread adoption and testing of SBrTMS as a viable alternative to HFL-TMS. Ultimately, this or a modification of it, may become the rTMS administration method of choice. Additionally, we will have a sufficient sample size to start to explore meaningful predictors of clinical response including biological, psychosocial-personality variable predictors.Read moreRead less
Advancing Novel Brain Stimulation Treatment For Severe Depression
Funder
National Health and Medical Research Council
Funding Amount
$575,662.00
Summary
The aim of the proposed research is to substantially escalate the development of a range of novel brain stimulation treatments for patients with severe treatment resistant depression (TRD). For example, to expand a substantive research program aimed at further developing methods for the application of repetitive transcranial magnetic stimulation (rTMS) in patients with depression.
Application Of Intelligent Conducting Polymers For Treating Schizophrenia And Allied Disorders Focusing On Neuronal Outgrowth, Myelination And Synaptogenesis
Funder
National Health and Medical Research Council
Funding Amount
$698,314.00
Summary
This project involves cross-disciplinary collaboration between researchers at the forefront of materials engineering, nanotechnology, neural pathology, human stem cell biology and mental health disciplines. We will use a nanodevice to apply electrical stimuli and growth factors to improve brain function in schizophrenia and allied disorders.
Personalised Brain Stimulation For Treatment Of Obsessive-Compulsive Disorder
Funder
National Health and Medical Research Council
Funding Amount
$666,128.00
Summary
Obsessive-Compulsive Disorder (OCD) affects more than 230,000 Australians, 25% of whom attempt suicide. This project will use a novel method to profile people with OCD based on patterns of brain activity and symptoms, and assess if such profiling can improve the efficacy of brain stimulation interventions for OCD. Results from this study will provide evidence supporting the use of personalised brain stimulation as a viable therapy for OCD.